학술논문
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
Document Type
Article
Author
Source
In Journal of Hepatology December 2022 77(6):1525-1531
Subject
Language
ISSN
0168-8278